Abstract
Objective: To evaluate aspects related to the mental and physical health of parkinson's patients and the impact of adverse effects of drug treatment on quality of life. Methods: A cross-sectional, non-experimental and descriptive study of quantitative approach was carried out, using as a research instrument the unified parkinsons' disease rating scale (UPDRS-ADAPTED), with prior signature of patients and/or guardian of the Informed Consent Form. Results: The sample consisted of 20 patients affected by Parkinson's disease and using antiparkinsonian medications. In general, these patients feel sad, but are not diagnosed with depression and do not have suicidal thoughts. In relation to daily life, they perceive a slowness, however they do not feel incapable and most can perform daily tasks without help. Pain in dyskinesias and dystoniaare the side effects most reported by the interviewed patients. Conclusion: From this study it was possible to observe that pharmacological treatment can contribute to improve the quality of life of the interviewees and that the results found corroborate studies already published on patients from other regions.